FLUCILONE-G Cream - Lomus Pharmaceuticals Pvt. Ltd.
FLUCILONE-G Cream - Lomus Pharmaceuticals Pvt. Ltd.
FLUCILONE-G Cream - Lomus Pharmaceuticals Pvt. Ltd.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>FLUCILONE</strong>-G <strong>Cream</strong><br />
Dosage Forms/Composition<br />
<strong>Cream</strong>: Fluocinolone Acetonide 0.025 % w/w<br />
Gentamicin 0.1 % w/w.<br />
Pharmacological Index<br />
Synthetic steroid with antibiotic.<br />
INDICATION<br />
Superficial infections of the skin caused by susceptible bacteria.<br />
Pregnancy Risk Factor<br />
C<br />
Contraindications<br />
Corticosteroids have been shown to be teratogenic in animals following dermal application. As<br />
agents are absorbed percutaneously teratogenicity following topical application cannot be<br />
excluded. Therefore Flucilone should not be used during pregnancy. Flucilone is contraindicated<br />
in the treatment of herpes simplex, vaccinia or varicella. Long-term use is contraindicated<br />
in patients with diabetes mellitus or tuberculosis. Flucilone should not be used on<br />
infants and young children.<br />
Warnings/Precautions<br />
The use of gentamicin may result in overgrowth of nonsusceptible organisms including<br />
fungi. If superinfection occurs during gentamicin therapy, the drug should be<br />
discontinued and appropriate therapy instituted. The possibility of cumulative toxicity<br />
should be considered if gentamicin is applied topically to large skin lesions or large<br />
areas of denuded skin in combination with systemic aminoglycoside therapy.<br />
Hypersensitive to the drug or any ingredients in the formulations.<br />
Adverse Reactions<br />
Usual Dosage<br />
Apply to the affected areas 2-3 times daily.<br />
Patient Information<br />
Do not apply to face, grain or axillae or cover with occlusive dressing unless ordered by<br />
the medical practitioners. Apply medication sparingly but in sufficient quantity to cover<br />
affected areas, and rub gently. Avoid eye contact.<br />
LOMUS Drug Information Center<br />
<strong>Lomus</strong> <strong>Pharmaceuticals</strong> <strong>Pvt</strong>. <strong>Ltd</strong>.<br />
P.O. Box No 4506, <strong>Lomus</strong> House (Corporate office),<br />
Kailash Chour, Lazimpat, Kathmandu, Nepal<br />
Ph: 4436396 (Hunting Line). Fx: 977-1-4436395<br />
E-mail: druginfo@lomus.com.np